Target intelligence / Profile preview

Nutrient digestibility

Molecular classification
Other
01

Overview

Nutrient digestibility is a physiological measure representing the proportion of ingested nutrients that are broken down and absorbed by the gastrointestinal tract into the systemic circulation (FAO, 2013). It is an aggregate outcome of various biochemical and mechanical processes, including mastication, enzymatic hydrolysis, and transport across the intestinal epithelium (StatPearls, 2023). Rather than being a discrete molecular target like a receptor or enzyme, nutrient digestibility serves as a clinical endpoint for assessing gastrointestinal health and metabolic efficiency. Therapeutic interventions often target specific components of this process; for instance, lipase inhibitors like Orlistat reduce fat digestibility to treat obesity by inhibiting gastric and pancreatic lipases (Guerciolini, 1997), while enzyme replacements enhance it in conditions like exocrine pancreatic insufficiency (NIH, 2022). Understanding digestibility is crucial for managing malabsorptive diseases such as Celiac disease or Crohn's disease, where structural damage to the intestinal mucosa impairs nutrient uptake (Mayo Clinic, 2023).

Other names
Digestive efficiencyApparent digestibilityNutrient bioavailabilityBioaccessibilityDigestive coefficient
02

Mechanism of action

Nutrient digestibility is a physiological outcome rather than a single molecular target. It is modulated by pharmacological agents that either inhibit digestive enzymes (e.g., Orlistat for lipases, Acarbose for alpha-glucosidases), replace deficient endogenous enzymes (e.g., pancrelipase), or alter gastrointestinal transit time and pH to facilitate or hinder the breakdown and transport of macronutrients across the intestinal mucosa (StatPearls, 2023; Guerciolini, 1997).

03

Biological functions

DigestionNutrient absorptionMetabolismEnergy homeostasis
04

Disease associations

Malabsorption syndromesExocrine pancreatic insufficiencyCeliac diseaseInflammatory bowel diseaseShort bowel syndromeObesity
05

Safety considerations

MalnutritionFat-soluble vitamin deficiency (A, D, E, K)SteatorrheaElectrolyte imbalanceWeight lossGastrointestinal distress
06

Interacting drugs

Pancrelipase

5 more in the full profile.

07

Biomarkers

Fecal fat excretionD-xylose absorption testSerum albuminSerum micronutrient levels (e.g., Vitamin B12, Iron, Ferritin)72-hour fecal fat collectionBreath hydrogen test

Beyond the preview

Go deeper on Nutrient digestibility.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrient digestibility.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call